SYMON-II Clinical trials Bluejay is successfully enrolling across all participating sites in its SYMON™ II multicenter IL-6 monitoring study, with a total of 545 patients enrolled with a target of 750 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results